ArticleReproduction & fertility2026
Pathogenic homozygous PLCZ1 mutation reduces sperm protein levels with a simulated reduction of PIP2 binding: a case report.
Article in Reproduction & fertility, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- A catalytically competent sperm PLCzeta variant causes fertilization failure through protein insufficiency.Journal of assisted reproduction and genetics · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
12 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Abstract: Mammalian oocyte activation is driven by intracellular calcium (Ca2+) oscillations induced by sperm-specific phospholipase C zeta (PLCζ). Sperm PLCζ deficiency is linked to male infertility caused by oocyte activation deficiency. Using whole exome sequencing, we report finding a previously reported loss-of-activity pathogenic mutation of PLCZ1 from two unrelated males in a separate ethnicity, homozygous in both cases. We examined sperm PLCζ using immunoblotting and immunofluorescence to compare levels with fertile control sperm. We also utilised bioinformatics tools to characterise the effect of this variant. The variant caused a guanine (G)-to-adenine (A) change at position 1,154 (c.1154G>A), resulting in an arginine (R)-to-glutamine (Q) change at amino acid 385 (p.Arg385Gln; R385Q), disrupting the local protein fold in the Y domain of the active site in a highly deleterious and pathogenic manner. A previous study identified this mutation as heterozygous, while we identified this variant as homozygous in an ethnically distinct population from this previous study. Sperm PLCζ was significantly reduced compared to controls. The R385Q change indicated a reduction in PIP2 interaction with PLCζ following docking analyses. Pathogenic PLCζ mutation may be common in men with repeated fertilisation failure. Raw ejaculate analysis, rather than density gradient washed sperm, could provide a more accurate assessment of PLCζ levels, especially in men with low sperm count or ejaculate volume. Such pathogenic cases may underlie higher proportions of sperm exhibiting abnormal PLCζ localisation and could stand to aid a larger number of patients seeking fertility treatment. Lay summary: In this study, we examined two unrelated men who had been unable to have children despite multiple in vitro fertilisation attempts. We discovered that both men carried the same mutation in a gene called PLCZ1. This gene normally produces a protein in sperm that tells the egg to begin developing into an embryo, but because of the mutation in these men, the sperm could not deliver that message to the egg. Interestingly, this same mutation had previously only been reported in Chinese patients, and this was the first time it was found in men from a different ethnic background, suggesting that this mutation may be a globally occurring mutation. This finding could help doctors recognise similar fertility problems in other patients and could lead to more effective treatments in the future.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.